First Trust Nasdaq Lux Digital Health Solutions ETFEKG

The First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) is a fee-collection vehicle masquerading as a thematic promise, and its Nasdaq listing page does the heavy lifting of looking important while the fund itself does the quiet work of tracking a rules-based index you’ll never read in plain English. The EKG ticker trades on Nasdaq like any other ETF, which means it’s a liquidity box where buyers and sellers swap tickets while the issuer calmly charges 0.60% per year for the pleasure, no questions asked. The wrapper’s marketing copy likely features a heartbeat line on a screen and the word “innovation” in bold, but the reality is a daily grind of rebalancing an index of digital-health companies whose own filings are the only ones doing any real disclosure. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/ekg)

The fund’s mandate is simple: own the Nasdaq Lux Digital Health Index, a collection of companies that either sell software to doctors or promise to digitise things humans already do without screens. The SEC’s EDGAR filing for EKG confirms the index name and the wrapper’s tracking method, but it doesn’t tell you what those companies actually earn, spend, or invent-because the fund doesn’t have to. The issuer’s prospectus is the only place EKG’s fee is spelled out in detail, and the number is 0.60%, which is less a medical miracle than a steady drip of revenue for the fund’s sponsor. (source: SEC EDGAR fund search for EKG, https://www.sec.gov/edgar/search/#/q=EKG)

What EKG actually holds is decided by Nasdaq’s index committee, not by EKG itself, which means the fund is a conduit for an index that may or may not survive the next wave of digital-health consolidation. The FINRA fund analyser confirms EKG’s expense ratio and trading venue, but it won’t tell you whether the index’s top holdings are growing revenue or just burning cash on regulatory approvals. That information lives in the index provider’s methodology and the holdings’ own filings, neither of which EKG discloses in its daily operations. The wrapper’s job is to replicate the index, not to vet the companies inside it. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)

If you want to see where EKG trades and how it behaves, the Nasdaq market-activity page gives you the ticker’s price, volume, and basic stats, but it won’t tell you whether the stocks inside are having a good day or a bad one. The chart is just a reflection of the index’s last price, not a signal about the fund’s health. For that, you’d need the index provider’s methodology and the holdings’ own disclosures-none of which are embedded in the EKG wrapper. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/ekg)

The fund’s current evidence base is thin: we know the expense ratio (0.60%), the trading venue (Nasdaq), the tracking index (Nasdaq Lux Digital Health), and the issuer’s fee extraction method. What we don’t know is the index’s current holdings, their concentrations, or the index provider’s latest methodology update. The SEC filing confirms the index name but not the constituents, and the FINRA analyser confirms the fee but not the index’s health. Without the index provider’s latest factsheet or the holdings’ filings, we can’t say whether the basket is thriving or merely surviving. The next step is to pull the Nasdaq Lux Digital Health index factsheet and cross-check it against the holdings’ recent filings to see if the theme is still beating the fee. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/ekg; SEC, https://www.sec.gov/edgar/search/#/q=EKG; FINRA, https://tools.finra.org/fund_analyzer/)